Use this to assess whether the organization is commercially and operationally relevant.
The U.S. Army Medical Research Acquisition Activity (USAMRAA), under the Defense Health Agency (DHA) and Army Medical Research and Development Command (USAMRDC), serves as the primary contracting and acquisition arm for biomedical research and development, focusing on delivering medical capabilities that enhance warfighter health, readiness, and lethality in combat environments. It manages contracts for cutting-edge technologies, including biological warfare defenses, infectious disease treatments like COVID-19 responses, and operational medical systems for austere battlefield conditions, supporting global combatant commands through innovation in battlefield medicine and force protection.